Found 10 matching trials
Efficacy and Safety of Tideglusib in Congenital Myotonic Dystrophy PHASE2 This is a randomized, multicenter, double-blind, placebo-controlled, Phase ...
Show More Location
Arkansas Children's Hospital
Learn More & Join Trial
Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy PHASE2 The TaRGET study is a multi-centre, prospective, randomized, double-blind, ...
Show More Location
University of Calgary
Learn More & Join Trial
Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112 Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy NA The purpose of this study is to determine wether NP031112 is safe and effec...
Show More Location
The Parkinson's and Movement Disorder Institute
Learn More & Join Trial
Tideglusib for the Treatment of Amyotrophic Lateral Sclerosis PHASE2 Amyotrophic lateral sclerosis (ALS) is a severe neurodegenerative condition...
Show More Location
University Hospital Bern
Learn More & Join Trial
Tideglusib: Expanded Access Use in Congenital Myotonic Dystrophy N/A This treatment plan is limited to a single patient with Congenital Myotonic...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy PHASE2 This is an open-label phase 2/3 study for individuals with Congenital Myoto...
Show More Location
Arkansas Children's Hospital
Learn More & Join Trial
Study of Tideglusib in Adolescent and Adult Patients With Myotonic Dystrophy PHASE2 The purpose of this study is to determine whether Tideglusib is safe and ef...
Show More Location
Newcastle-upon-Tyne Hospitals NHS Trust
Learn More & Join Trial
Safety Study of a Glycogen Synthase Kinase 3 (GSK3) Inhibitor in Patients With Alzheimer´s Disease PHASE1 The purpose of this study is to evaluate if 4 escalating doses during 20 we...
Show More Location
Pharmacologische Studiecentrum Chemnitz
Learn More & Join Trial
Efficacy, Safety and Tolerability of Tideglusib to Treat Mild-to-Moderate Alzheimer's Disease Patients PHASE2 The main purpose of this study is to evaluate the cognitive changes after a...
Show More Location
Multiple Locations
Learn More & Join Trial
Tideglusib vs. Placebo in the Treatment of Adolescents With Autism Spectrum Disorders PHASE2 This study will examine the safety and efficacy of tideglusib vs. placebo f...
Show More Location
McMaster University, Offord Centre for Child Studies
Learn More & Join Trial